Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Field
-
Europe | 27 days ago
approaches for telecommunicationsHost institution: UNILIM, FranceSupervisors: Prof. P. Roy (UNILIM)DC 10 – OpenProject Title: Design of wavelength space division multiplexing MCF-based passive optical networks
-
CSIRO IPhD Scholarship - AI-empowered visual recognition system for dairy cow identification, health and behaviour monitoring and detection The CSIRO Industry PhD Program (iPhD) is a four-year
-
including machine learning. This research will support the path to net zero flights and there will be opportunities to become involved in practical aspects of fuel system design and testing during their PhD
-
time (25,025 h/week) PhD position (f/m/d) in Spatial Cancer Biology he Brägelmann Lab at the University Hospital Bonn (UKB), University of Bonn, is seeking a highly motivated PhD candidate to join our
-
Description At the Faculty of Chemistry and Food Chemistry, the Chair of Theoretical Chemistry offers a position as Research Associate / PhD Student (m/f/x) (subject to personal qualification
-
Location: UK Other Applications are invited to undertake a PhD programme, in partnership with Airbus, to address key challenges in ensuring adoption of sustainable approaches to fuel additives
-
of Australia’s leading health services research environments with other PhD students, research staff and members of the dynamic Australian Centre for Health Services Innovation
-
analysis, focused on selected electrodes or brain regions. We would like to investigate how graph deep learning models can be designed to capture dynamics in brain signals for the accurate detection, and how
-
). In the context of Prof. Fridgen’s PayPal-FNR PEARL Research Grant and in strong synergy and collaboration with the FutureFinTech National Center of Excellence in Research and Innovation, the successful
-
bioinformatic skills to predict the evolution of rare diseases? FSHD is a rare neuromuscular disorder. No approved treatment is currently available. Slow and variable disease progression complicate trial design